OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin
Tae Hyun Ban, Sua Lee, Hyung Duk Kim, et al.
Stem Cells International (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 11
Tae Hyun Ban, Sua Lee, Hyung Duk Kim, et al.
Stem Cells International (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 11
Showing 11 citing articles:
Small extracellular vesicles from mesenchymal stem cells: A potential Weapon for chronic non-healing wound treatment
Wei Qian, Xi Liu, Jianlong Su, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 10
Open Access | Times Cited: 15
Wei Qian, Xi Liu, Jianlong Su, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 10
Open Access | Times Cited: 15
Clinical Prospect of Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles in Kidney Disease: Challenges and the Way Forward
Maja Kosanović, Bojana Milutinović, Tanja J. Kutzner, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1911-1911
Open Access | Times Cited: 12
Maja Kosanović, Bojana Milutinović, Tanja J. Kutzner, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1911-1911
Open Access | Times Cited: 12
Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions
Leonard Knoedler, J. H. Dean, Fortunay Diatta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Leonard Knoedler, J. H. Dean, Fortunay Diatta, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Toward transplantation tolerance with adipose tissue-derived therapeutics
Hui-Yun Cheng, Madonna Rica Anggelia, Cheng‐Hung Lin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Hui-Yun Cheng, Madonna Rica Anggelia, Cheng‐Hung Lin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series
Željka Večerić‐Haler, Matjaž Sever, Nika Kojc, et al.
Transplant International (2022) Vol. 35
Open Access | Times Cited: 11
Željka Večerić‐Haler, Matjaž Sever, Nika Kojc, et al.
Transplant International (2022) Vol. 35
Open Access | Times Cited: 11
Efficacy and Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Antibody-Mediated Rejection After Kidney Transplantation- A Single-Arm, Two-Dosing-Regimen, Phase I/II Study
Yongcheng Wei, Xiaoyong Chen, Huanxi Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 13
Yongcheng Wei, Xiaoyong Chen, Huanxi Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 13
Safety of Allogeneic Mesenchymal Stem Cell Seeding of NeuraGen Nerve Guides in a Rabbit Model
Meiwand Bedar, André J. van Wijnen, Alexander Y. Shin
Tissue Engineering Part C Methods (2023) Vol. 29, Iss. 2, pp. 43-53
Open Access | Times Cited: 1
Meiwand Bedar, André J. van Wijnen, Alexander Y. Shin
Tissue Engineering Part C Methods (2023) Vol. 29, Iss. 2, pp. 43-53
Open Access | Times Cited: 1
Allogeneic Mesenchymal Stem Cells After In Vivo Transplantation: A Review
Derek B. Asserson
Cellular Reprogramming (2023) Vol. 25, Iss. 6, pp. 264-276
Closed Access | Times Cited: 1
Derek B. Asserson
Cellular Reprogramming (2023) Vol. 25, Iss. 6, pp. 264-276
Closed Access | Times Cited: 1
Combined Use of Tocilizumab and Mesenchymal Stem Cells Attenuate the Development of an Anti-HLA-A2.1 Antibody in a Highly Sensitized Mouse Model
Xianying Fang, Sheng Cui, Hanbi Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1378-1378
Open Access
Xianying Fang, Sheng Cui, Hanbi Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1378-1378
Open Access
Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?
Suzanne Bezstarosti, Pauline Erpicum, Gianni Maggipinto, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Suzanne Bezstarosti, Pauline Erpicum, Gianni Maggipinto, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Stem Cell Delivery Routes: From Preclinical Models to Clinical Applications
Sharmila Fagoonee
(2021)
Open Access | Times Cited: 2
Sharmila Fagoonee
(2021)
Open Access | Times Cited: 2
